Optimal composite scores for longitudinal clinical trials under the linear mixed effects model-Reference-Cited by-同舟云学术

Optimal composite scores for longitudinal clinical trials under the linear mixed effects model

Published:2015-07-30 Issue:5 Volume:14 Page:418-426
ISSN:1539-1604
Container-title:Pharmaceutical Statistics
language:en
Short-container-title:Pharmaceut. Statist.

Author:

Ard M. Colin¹,Raghavan Nandini²,Edland Steven D.¹³

Affiliation:

1. Department of Neurosciences University of California, San Diego La Jolla CA USA

2. Janssen Research & Development, LLC Raritan NJ USA

3. Division of Biostatistics, Department of Family and Preventive Medicine University of California San Diego, La Jolla CA USA

Funder

National Institute on Aging

Janssen Research and Development

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology,Statistics and Probability

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pst.1701

Reference16 articles.

1. Improved Statistical Power of Alzheimer Clinical Trials by Item-Response Theory

2. Power calculations for clinical trials in Alzheimer's disease;Ard MC;Journal of Alzheimer's Disease,2011

3. US Dept of Health and Human Services; US Food and Drug Administration; Center for Drug Evaluation and Research.Guidance for industry: Alzheimer's disease: developing drugs for the treatment of early stage disease (draft guidance). Available at:http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM338287.pdf. (Published February 2013. Accessed 19 June 2014).

4. Regulatory Innovation and Drug Development for Early-Stage Alzheimer's Disease

5. The ADAS‐Cog revisited: Novel composite scales based on ADAS‐Cog to improve efficiency in MCI and early AD trials

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of new outcome measures for adult SMA type III and IV: a multimodal longitudinal study;Journal of Neurology;2021-01-02

2. Assessing Change in Intervention Research: The Benefits of Composite Outcomes;Advances in Methods and Practices in Psychological Science;2021-01

3. Community memory screening as a strategy for recruiting older adults into Alzheimer’s disease research;Alzheimer's Research & Therapy;2020-06-30

4. Multilevel Modeling and the Explanatory Autonomy of Psychology;Philosophy of the Social Sciences;2020-05-20

5. Response to: Counterpoint to Jin et al, On weighted composite scores for early Alzheimer's trials. Pharm Stat. 18(2):239‐47, 2019, DOI: 10.1002/pst.1920;Pharmaceutical Statistics;2020-03-08